找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

(版塊PHARMACOLOGY & PHARMACY(藥理學與藥學)版塊期刊總數(shù):274)
新窗
投票 SCIE期刊International Journal for Parasitology-Drugs and Drug Resistance 2024/2025影響因子:4.165 (INT J PARASITOL-DRUG) (2211  ...234
Total Citations:1672; 2023 JIF:4.165; JIFRank: 78/354 ; Rank-JIF: 78; Number-of-JIF:354; 5 Year JIF:3.798; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.9; Immediacy Index:0.8; Immediacy Index-dealt:0.869; 2023 JCI:1.15; JCI Rank: 61/354 ; Total Articles:39; JCI Quartile:Q1; JCI Percentile:82.91; Eigenfactor:0.002; Normalized Eigenfactor:0.467; Article Influence Score:0.977; JIF Percentile:78.1; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:39; % of Articles in Citable items:1; Cited Half-Life:5; Citing Half-Life:9.7; % of OA Gold:0.9254; Publisher name:SISMEL EDIZIONI GALLUZZO; Publisher address:CASELLA POSTALE 90, TAVARNUZZE, Italy, 50
投票 SCIE期刊PHARMACOGENOMICS 2024/2025影響因子:1.967 (PHARMACOGENOMICS) (1462-2416). (PHARMACOLOGY & PHARMACY)(藥理學與藥學)Science Cit  ...234
Total Citations:3248; 2023 JIF:1.967; JIFRank: 231/354 ; Rank-JIF: 231; Number-of-JIF:354; 5 Year JIF:1.924; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.7; Immediacy Index:0.6; Immediacy Index-dealt:0.661; 2023 JCI:0.44; JCI Rank: 257/354 ; Total Articles:60; JCI Quartile:Q3; JCI Percentile:27.54; Eigenfactor:0.002; Normalized Eigenfactor:0.409; Article Influence Score:0.46; JIF Percentile:34.9; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:75; % of Articles in Citable items:0.8; Cited Half-Life:8.9; Citing Half-Life:6.6; % of OA Gold:0.1116; Publisher name:SPRINGER; Publisher address:ONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, United S
投票 SCIE期刊VASCULAR PHARMACOLOGY 2024/2025影響因子:3.532 (VASC PHARMACOL) (1537-1891). (PHARMACOLOGY & PHARMACY)(藥理學與藥學)Science  ...234
Total Citations:3382; 2023 JIF:3.532; JIFRank: 100/354 ; Rank-JIF: 100; Number-of-JIF:354; 5 Year JIF:4.159; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.4; Immediacy Index:0.5; Immediacy Index-dealt:0.558; 2023 JCI:1.24; JCI Rank: 52/354 ; Total Articles:65; JCI Quartile:Q1; JCI Percentile:85.45; Eigenfactor:0.003; Normalized Eigenfactor:0.556; Article Influence Score:0.919; JIF Percentile:71.9; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:68; % of Articles in Citable items:0.9559; Cited Half-Life:7.4; Citing Half-Life:7.4; % of OA Gold:0.2745; Publisher name:SAGE PUBLICATIONS LTD; Publisher address:1 OLIVERS YARD, 55 CITY ROAD, LONDO
投票 SCIE期刊AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION 2024/2025影響因子:3.834 (AM J PHARM EDUC) (0002-9459). (PHARMACOLOGY & P  ...234
Total Citations:6433; 2023 JIF:3.834; JIFRank: 89/354 ; Rank-JIF: 89; Number-of-JIF:354; 5 Year JIF:3.811; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.3; Immediacy Index:0.8; Immediacy Index-dealt:0.822; 2023 JCI:0.97; JCI Rank: 88/354 ; Total Articles:168; JCI Quartile:Q1; JCI Percentile:75.28; Eigenfactor:0.004; Normalized Eigenfactor:0.862; Article Influence Score:0.736; JIF Percentile:75; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:198; % of Articles in Citable items:0.8485; Cited Half-Life:7.3; Citing Half-Life:6.9; % of OA Gold:0.7927; Publisher name:CZECH ACADEMY AGRICULTURAL SCIENCES; Publisher address:TESNOV 17, PRAGUE, CZEC
投票 SCIE期刊IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY 2024/2025影響因子:2.968 (IMMUNOPHARM IMMUNOT) (0892-3973). (PHARMACOLOGY & PH  ...234
Total Citations:2870; 2023 JIF:2.968; JIFRank: 147/354 ; Rank-JIF: 147; Number-of-JIF:354; 5 Year JIF:3.236; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.9; Immediacy Index:0.8; Immediacy Index-dealt:0.881; 2023 JCI:0.71; JCI Rank: 162/354 ; Total Articles:51; JCI Quartile:Q2; JCI Percentile:54.38; Eigenfactor:0.002; Normalized Eigenfactor:0.449; Article Influence Score:0.612; JIF Percentile:58.6; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:59; % of Articles in Citable items:0.8644; Cited Half-Life:6.7; Citing Half-Life:6.5; % of OA Gold:0.0426; Publisher name:TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, MILTON PARK, ABING
投票 SCIE期刊Journal of Clinical Lipidology 2024/2025影響因子:3.643 (J CLIN LIPIDOL) (1933-2874). (PHARMACOLOGY & PHARMACY)(藥理學與藥學  ...234
Total Citations:3960; 2023 JIF:3.643; JIFRank: 94/354 ; Rank-JIF: 94; Number-of-JIF:354; 5 Year JIF:3.837; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.3; Immediacy Index:1.3; Immediacy Index-dealt:1.341; 2023 JCI:1.12; JCI Rank: 66/354 ; Total Articles:77; JCI Quartile:Q1; JCI Percentile:81.5; Eigenfactor:0.005; Normalized Eigenfactor:1.138; Article Influence Score:1.242; JIF Percentile:73.6; JIF Quartile:Q2; AIS Quartile:Q1; Citable Items:83; % of Articles in Citable items:0.9277; Cited Half-Life:5.9; Citing Half-Life:6.8; % of OA Gold:0.2539; Publisher name:PARIS SCHOLAR PUBLISHING LTD; Publisher address:1508 S GARFIELD AVE, ALHAMBRA,
投票 SCIE期刊JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION 2024/2025影響因子:2.506 (J AM PHARM ASSOC) (1544-3191). (PHARMACOLOGY  ...234
Total Citations:4062; 2023 JIF:2.506; JIFRank: 180/354 ; Rank-JIF: 180; Number-of-JIF:354; 5 Year JIF:2.315; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.1; Immediacy Index:0.8; Immediacy Index-dealt:0.861; 2023 JCI:0.61; JCI Rank: 199/354 ; Total Articles:187; JCI Quartile:Q3; JCI Percentile:43.93; Eigenfactor:0.004; Normalized Eigenfactor:0.957; Article Influence Score:0.609; JIF Percentile:49.3; JIF Quartile:Q3; AIS Quartile:Q2; Citable Items:208; % of Articles in Citable items:0.899; Cited Half-Life:5.6; Citing Half-Life:6.7; % of OA Gold:0.1075; Publisher name:TAYLOR & FRANCIS INC; Publisher address:530 WALNUT STREET, STE 850, PHILAD
投票 SCIE期刊EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 2024/2025影響因子:2.481 (EUR J CLIN PHARMACOL) (0031-6970). (PHARMACOLOGY &  ...234
Total Citations:7968; 2023 JIF:2.481; JIFRank: 188/354 ; Rank-JIF: 188; Number-of-JIF:354; 5 Year JIF:2.567; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.3; Immediacy Index:0.4; Immediacy Index-dealt:0.481; 2023 JCI:0.62; JCI Rank: 192/354 ; Total Articles:108; JCI Quartile:Q3; JCI Percentile:45.9; Eigenfactor:0.005; Normalized Eigenfactor:1.142; Article Influence Score:0.702; JIF Percentile:47; JIF Quartile:Q3; AIS Quartile:Q2; Citable Items:153; % of Articles in Citable items:0.7059; Cited Half-Life:10.2; Citing Half-Life:6.9; % of OA Gold:0.3262; Publisher name:PERGAMON-ELSEVIER SCIENCE LTD; Publisher address:THE BOULEVARD, LANGFORD LA
投票 SCIE期刊INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES 2024/2025影響因子:0.437 (INDIAN J PHARM SCI) (0250-474X). (PHARMACOLOGY & P  ...234
Total Citations:3350; 2023 JIF:0.437; JIFRank: 335/354 ; Rank-JIF: 335; Number-of-JIF:354; 5 Year JIF:0.694; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.4; Immediacy Index:<0.1; Immediacy Index-dealt:0.009; 2023 JCI:0.11; JCI Rank: 337/354 ; Total Articles:388; JCI Quartile:Q4; JCI Percentile:4.94; Eigenfactor:0.001; Normalized Eigenfactor:0.219; Article Influence Score:0.089; JIF Percentile:5.5; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:414; % of Articles in Citable items:0.9372; Cited Half-Life:11.3; Citing Half-Life:6.5; % of OA Gold:0.2351; Publisher name:SPRINGER INT PUBL AG; Publisher address:GEWERBESTRASSE 11, CHAM, SWITZERL
投票 SCIE期刊Neurotherapeutics 2024/2025影響因子:5.618 (NEUROTHERAPEUTICS) (1933-7213). (PHARMACOLOGY & PHARMACY)(藥理學與藥學)Science C  ...234
Total Citations:8591; 2023 JIF:5.618; JIFRank: 31/354 ; Rank-JIF: 31; Number-of-JIF:354; 5 Year JIF:6.993; 5 Year JIF Quartile:Q1; JIF Without Self Cites:5.5; Immediacy Index:1.3; Immediacy Index-dealt:1.313; 2023 JCI:1.39; JCI Rank: 35/354 ; Total Articles:65; JCI Quartile:Q1; JCI Percentile:86.29; Eigenfactor:0.01; Normalized Eigenfactor:2.204; Article Influence Score:1.843; JIF Percentile:86.9; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:108; % of Articles in Citable items:0.6019; Cited Half-Life:5.6; Citing Half-Life:7.7; % of OA Gold:0.9833; Publisher name:BRILL; Publisher address:PLANTIJNSTRAAT 2, P O BOX 9000, LEIDEN, NETHERLANDS,
投票 SCIE期刊ACTA POLONIAE PHARMACEUTICA 2024/2025影響因子:0.454 (ACTA POL PHARM) (0001-6837). (PHARMACOLOGY & PHARMACY)(藥理學與藥學)Sc  ...234
Total Citations:1879; 2023 JIF:0.454; JIFRank: 335/354 ; Rank-JIF: 335; Number-of-JIF:354; 5 Year JIF:0.481; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.3; Immediacy Index:0.1; Immediacy Index-dealt:0.195; 2023 JCI:0.11; JCI Rank: 337/354 ; Total Articles:73; JCI Quartile:Q4; JCI Percentile:4.94; Eigenfactor:0; Normalized Eigenfactor:0.054; Article Influence Score:0.056; JIF Percentile:5.5; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:88; % of Articles in Citable items:0.8295; Cited Half-Life:12.1; Citing Half-Life:7.1; % of OA Gold:0.883; Publisher name:GEOGRAFSKI INST ANTONA MELIKA ZRC SAZU; Publisher address:GOSPOSKA ULICA 13, LJUB
投票 SCIE期刊Personalized Medicine 2024/2025影響因子:1.784 (PERS MED) (1741-0541). (PHARMACOLOGY & PHARMACY)(藥理學與藥學)Science Citati  ...234
Total Citations:935; 2023 JIF:1.784; JIFRank: 251/354 ; Rank-JIF: 251; Number-of-JIF:354; 5 Year JIF:1.912; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.7; Immediacy Index:0.7; Immediacy Index-dealt:0.764; 2023 JCI:0.5; JCI Rank: 236/354 ; Total Articles:31; JCI Quartile:Q3; JCI Percentile:33.47; Eigenfactor:0.001; Normalized Eigenfactor:0.185; Article Influence Score:0.463; JIF Percentile:29.2; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:40; % of Articles in Citable items:0.775; Cited Half-Life:6.2; Citing Half-Life:5.8; % of OA Gold:0.1061; Publisher name:SPRINGER INDIA; Publisher address:7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA R
投票 SCIE期刊HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL 2024/2025影響因子:1.805 (HUM PSYCHOPHARM CLIN) (0885-6222). (PHARM  ...234
Total Citations:1866; 2023 JIF:1.805; JIFRank: 240/354 ; Rank-JIF: 240; Number-of-JIF:354; 5 Year JIF:1.728; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.8; Immediacy Index:0.2; Immediacy Index-dealt:0.223; 2023 JCI:0.5; JCI Rank: 236/354 ; Total Articles:16; JCI Quartile:Q3; JCI Percentile:33.47; Eigenfactor:0.001; Normalized Eigenfactor:0.154; Article Influence Score:0.488; JIF Percentile:32.3; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:22; % of Articles in Citable items:0.7273; Cited Half-Life:11.9; Citing Half-Life:8.8; % of OA Gold:0.2747; Publisher name:WARSAW SCH ECONOMICS; Publisher address:AL NIEPODLEGLOSCI 162, WARSAW, POLA
投票 SCIE期刊JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS 2024/2025影響因子:2.166 (J CLIN PHARM THER) (0269-4727). (PHARMACOLOGY  ...234
Total Citations:4096; 2023 JIF:2.166; JIFRank: 210/354 ; Rank-JIF: 210; Number-of-JIF:354; 5 Year JIF:2.188; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.1; Immediacy Index:<0.1; Immediacy Index-dealt:0.041; 2023 JCI:0.46; JCI Rank: 253/354 ; Total Articles:42; JCI Quartile:Q3; JCI Percentile:28.67; Eigenfactor:0.004; Normalized Eigenfactor:0.982; Article Influence Score:0.58; JIF Percentile:40.8; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:55; % of Articles in Citable items:0.7636; Cited Half-Life:6.2; Citing Half-Life:6.5; % of OA Gold:0.7639; Publisher name:BMC; Publisher address:CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW;
投票 SCIE期刊ChemMedChem 2024/2025影響因子:3.618 (CHEMMEDCHEM) (1860-7179). (PHARMACOLOGY & PHARMACY)(藥理學與藥學)Science Citation Inde  ...234
Total Citations:9552; 2023 JIF:3.618; JIFRank: 94/354 ; Rank-JIF: 94; Number-of-JIF:354; 5 Year JIF:3.571; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.5; Immediacy Index:0.8; Immediacy Index-dealt:0.861; 2023 JCI:0.85; JCI Rank: 112/354 ; Total Articles:174; JCI Quartile:Q2; JCI Percentile:68.5; Eigenfactor:0.007; Normalized Eigenfactor:1.631; Article Influence Score:0.713; JIF Percentile:73.6; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:202; % of Articles in Citable items:0.8614; Cited Half-Life:6.4; Citing Half-Life:7.2; % of OA Gold:0.2709; Publisher name:PERGAMON-ELSEVIER SCIENCE LTD; Publisher address:THE BOULEVARD, LANGFORD LAN
投票 SCIE期刊Expert Review of Neurotherapeutics 2024/2025影響因子:3.494 (EXPERT REV NEUROTHER) (1473-7175). (PHARMACOLOGY & PHARMA  ...234
Total Citations:5307; 2023 JIF:3.494; JIFRank: 105/354 ; Rank-JIF: 105; Number-of-JIF:354; 5 Year JIF:4.611; 5 Year JIF Quartile:Q1; JIF Without Self Cites:3.3; Immediacy Index:0.8; Immediacy Index-dealt:0.825; 2023 JCI:0.64; JCI Rank: 183/354 ; Total Articles:28; JCI Quartile:Q3; JCI Percentile:48.45; Eigenfactor:0.004; Normalized Eigenfactor:0.881; Article Influence Score:1.204; JIF Percentile:70.5; JIF Quartile:Q2; AIS Quartile:Q1; Citable Items:108; % of Articles in Citable items:0.2593; Cited Half-Life:8.2; Citing Half-Life:7; % of OA Gold:0.1466; Publisher name:SPRINGERNATURE; Publisher address:CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9
投票 SCIE期刊BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 2024/2025影響因子:3.128 (BRIT J CLIN PHARMACO) (0306-5251). (PHARMACOLOGY &  ...234
Total Citations:17303; 2023 JIF:3.128; JIFRank: 126/354 ; Rank-JIF: 126; Number-of-JIF:354; 5 Year JIF:3.744; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3; Immediacy Index:0.4; Immediacy Index-dealt:0.493; 2023 JCI:0.81; JCI Rank: 124/354 ; Total Articles:245; JCI Quartile:Q2; JCI Percentile:65.11; Eigenfactor:0.016; Normalized Eigenfactor:3.428; Article Influence Score:1.109; JIF Percentile:64.5; JIF Quartile:Q2; AIS Quartile:Q1; Citable Items:292; % of Articles in Citable items:0.839; Cited Half-Life:8.5; Citing Half-Life:7.6; % of OA Gold:0.4597; Publisher name:SPRINGER; Publisher address:VAN GODEWIJCKSTRAAT 30, DORDRECHT, NETHERLANDS,
投票 SCIE期刊Clinical Psychopharmacology and Neuroscience 2024/2025影響因子:2.406 (CLIN PSYCHOPHARM NEU) (1738-1088). (PHARMACOLOG  ...234
Total Citations:1551; 2023 JIF:2.406; JIFRank: 188/354 ; Rank-JIF: 188; Number-of-JIF:354; 5 Year JIF:2.857; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2; Immediacy Index:0.6; Immediacy Index-dealt:0.637; 2023 JCI:0.64; JCI Rank: 183/354 ; Total Articles:61; JCI Quartile:Q3; JCI Percentile:48.45; Eigenfactor:0.002; Normalized Eigenfactor:0.405; Article Influence Score:0.659; JIF Percentile:47; JIF Quartile:Q3; AIS Quartile:Q2; Citable Items:80; % of Articles in Citable items:0.7625; Cited Half-Life:4.7; Citing Half-Life:9.2; % of OA Gold:1; Publisher name:INST TECNOLOGIA PARANA; Publisher address:RUA PROF ALGACYR MUNHOZ MADER 3775-CIC, CU
投票 SCIE期刊Brazilian Journal of Pharmaceutical Sciences 2024/2025影響因子:0.606 (BRAZ J PHARM SCI) (1984-8250). (PHARMACOLOGY &  ...234
Total Citations:2115; 2023 JIF:0.606; JIFRank: 326/354 ; Rank-JIF: 326; Number-of-JIF:354; 5 Year JIF:1.161; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.6; Immediacy Index:0.1; Immediacy Index-dealt:0.116; 2023 JCI:0.22; JCI Rank: 309/354 ; Total Articles:135; JCI Quartile:Q4; JCI Percentile:12.85; Eigenfactor:0.001; Normalized Eigenfactor:0.224; Article Influence Score:0.139; JIF Percentile:8.1; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:139; % of Articles in Citable items:0.9712; Cited Half-Life:6.5; Citing Half-Life:9; % of OA Gold:0.9163; Publisher name:TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, MILTON PARK, ABINGD
投票 SCIE期刊TOXICON 2024/2025影響因子:2.633 (TOXICON) (0041-0101). (PHARMACOLOGY & PHARMACY)(藥理學與藥學)Science Citation Index Expand  ...234
Total Citations:11614; 2023 JIF:2.633; JIFRank: 173/354 ; Rank-JIF: 173; Number-of-JIF:354; 5 Year JIF:2.713; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.3; Immediacy Index:0.4; Immediacy Index-dealt:0.409; 2023 JCI:0.73; JCI Rank: 154/354 ; Total Articles:252; JCI Quartile:Q2; JCI Percentile:55.19; Eigenfactor:0.005; Normalized Eigenfactor:1.176; Article Influence Score:0.553; JIF Percentile:42.9; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:266; % of Articles in Citable items:0.9474; Cited Half-Life:11.8; Citing Half-Life:8.6; % of OA Gold:0.1589; Publisher name:CAMBRIDGE UNIV PRESS; Publisher address:EDINBURGH BLDG, SHAFTESBURY RD,
下一頁 »
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-4 22:54
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
返回頂部 返回版塊
明光市| 文安县| 遂溪县| 临泽县| 中江县| 芜湖县| 乌苏市| 东台市| 定陶县| 固原市| 江山市| 古浪县| 塘沽区| 广安市| 边坝县| 莫力| 沽源县| 安阳市| 措美县| 高雄县| 溆浦县| 麟游县| 达日县| 青铜峡市| 徐闻县| 彭泽县| 彰武县| 如皋市| 遂川县| 乐安县| 宽城| 辰溪县| 上犹县| 南京市| 博湖县| 孟津县| 仪陇县| 衢州市| 大港区| 甘肃省| 西充县|